BioSpace News Archive

Deals

MedMen Acquires First Dispensary in San Francisco Bay Area

Company Expands Footprint in its Home State into Northern California

October 10, 2018
·
6 min read
Drug Development

TapImmune’s HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded by an $11 Million U.S. Department of Defense Grant

Mayo Clinic Receives $11 Million to Study TPIV110 in Combination with Trastuzumab (Herceptin®)

October 10, 2018
·
4 min read
Deals

Kodiak Sciences Inc. Announces Closing of Initial Public Offering

Kodiak Sciences Inc. today announced the closing on October 9, 2018 of its initial public offering of 9,000,000 shares of common stock at a price to the public of $10.00 per share.

October 10, 2018
·
1 min read
Drug Development

Epizyme to Present Updated Data on Tazemetostat from Full Phase 2 Study Cohort in Epithelioid Sarcoma at ESMO

Company to Host Investor Conference Call on October 22, 2018 at 8:30 am EDT

October 10, 2018
·
6 min read
Business

ROSLINCT and REPROCELL Awarded £1.2 Million from Innovate UK for Clinical-Grade Stem Cell Production

Funding will be used to improve efficiency of induced pluripotent stem cell production

October 10, 2018
·
2 min read
Deals

OTC Markets Group Welcomes MPX Bioceutical Corporation to OTCQX

OTC Markets Group Inc. today announced MPX Bioceutical Corporation (CSE: MPX; OTCQX: MPXEF), a multi-state diversified cannabis company with operations focused in the U.S. in the adult use and medical cannabis markets, has qualified to trade on the OTCQX® Best Market.

October 10, 2018
·
2 min read
Pharm Country

Phesi Selected as Finalist for 2018 Scrip Award

Phesi, a technology-enabled, data-driven provider of premier clinical development services, today announced it is a finalist for a 2018 Scrip Award, one of the pharmaceutical and biotech industries’ most prestigious honors.

October 10, 2018
·
2 min read
BioMidwest

Calyxt Harvests High-Fiber Wheat Field Trials

Harvest Brings Calyxt One Step Closer to Commercializing First High Fiber Wheat Product for Consumers

October 10, 2018
·
4 min read
Deals

Quest Diagnostics Completes Acquisition of Provant Health, Extending Health and Wellness Services

Bolsters company’s expert screening and intervention services for employers and managed populations

October 10, 2018
·
3 min read
Business

Mario G. Pennisi, Australian Life Sciences Industry Leader, Joins Elo-Australia as Resident Director

Elo Life Systems Inc. announced today that Mario G. Pennisi joined Elo Life Systems as a Resident Director of its Australian subsidiary located on the premises of the Queensland University of Technology (QUT), Garden Point Campus in Brisbane.

October 10, 2018
·
2 min read